Zobrazeno 1 - 10
of 785
pro vyhledávání: '"RECURRENT HEPATITIS"'
Autor:
V. E. Syutkin, O. D. Olisov, A. A. Salienko, B. I. Yaremin, K. M. Magomedov, K. N. Lutsyk, M. S. Novruzbekov
Publikováno v:
Трансплантология (Москва), Vol 15, Iss 4, Pp 450-463 (2023)
Background. The terminal stages of chronic hepatitis C remain the main indication for liver transplantation in Russia and in the world.Aim. To retrospectively evaluate the changes in the waiting list of liver transplantation that occurred during 22 y
Externí odkaz:
https://doaj.org/article/0f37440031054c0cb8fe945d6be46fae
Autor:
S. E. Voskanyan, V. E. Syutkin, M. V. Shabalin, A. I. Artemyev, I. Yu. Kolyshev, A. N. Bashkov, A. M. Borbat, K. K. Gubarev, M. V. Popov, A. P. Maltseva
Publikováno v:
Трансплантология (Москва), Vol 12, Iss 4, Pp 319-331 (2020)
We present an uncommon case of liver graft dysfunction caused by seronegative hepatitis C-related fibrosing cholestatic hepatitis after cadaver liver transplantation for unresectable liver metastases of neuroendocrine small intestine cancer followed
Externí odkaz:
https://doaj.org/article/ae911eb66c924b8d89f713e408381401
Autor:
Diego Rincón, Aránzazu Caballero-Marcos, Ainhoa Fernández-Yunquera, Lucia Dieguez, Cristina Navarrete, Ana Clemente, Rafael Bañares Cañizares, Magdalena Salcedo, Mario Romero-Cristóbal, Marta Puerto, Fernando Diaz-Fontenla, Pilar Catalán, José-Ángel López-Baena
Publikováno v:
Transplant International. 34:2214-2225
The increased risk of cardiovascular disease (CVD) conferred by hepatitis C virus (HCV) is especially relevant after liver transplantation (LT), but its mechanism is still not well defined. This study aimed to evaluate the influence of HCV eradicatio
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Chinese Medical Journal
Chinese Medical Journal, Vol 134, Iss 19, Pp 2388-2390 (2021)
Chinese Medical Journal, Vol 134, Iss 19, Pp 2388-2390 (2021)
Autor:
Muhammad, Haris, Zaffar, Duha, Tehreem, Aniqa, Ting, Peng-Sheng, Simsek, Cem, Turan, Ilker, Alqahtani, Saleh
The ideal management for end stage liver disease, acute liver failure, and hepatocellular carcinoma (HCC), within specific criteria, is liver transplantation (LT). Over the years, there has been a steady increase in the candidates listed for LT, with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______9436::86022b400cf7ec327def9c20b13421c2
https://hdl.handle.net/11454/78525
https://hdl.handle.net/11454/78525
Publikováno v:
Gut and Liver, Vol 5, Iss 2, Pp 248-252 (2011)
A 60-year-old woman with end stage liver cirrhosis caused by genotype 2 hepatitis C virus (HCV) infection received an orthotopic liver transplantation (OLT). The patient was negative for the hepatitis B surface antigen (HBsAg) and positive for the an
Externí odkaz:
https://doaj.org/article/51cee35999084d0eb3616752e1d38eed
Publikováno v:
Gut and Liver, Vol 4, Iss 2, Pp 253-257 (2010)
A 47-year-old woman underwent orthotopic liver transplantation (OLT) for hepatitis B virus (HBV)-related end-stage liver cirrhosis. The patient received hepatitis B immunoglobulin prophylaxis after OLT. Despite the protective level of the serum anti-
Externí odkaz:
https://doaj.org/article/c62b905855fd41f8a76654355cd02c8d
Autor:
Maha Mohsen Kamal El-Din, Wael A. Yousry, Mohamed Mohamed Bahaa El-Din, Mohamed Saleh Ismail, Osama Aboelfotoh El Sayed, Prasun Jalal Kumar
Publikováno v:
QJM: An International Journal of Medicine. 114
BACKGROUND & AIMS Recurrent hepatitis C virus (HCV) infection of transplanted liver allografts is universal in patients with detectable HCV viremia at the time of transplantation. Directacting antiviral (DAA) therapy has been adopted as the standard
Publikováno v:
International Journal of Medical Sciences, Vol 3, Iss 2, Pp 79-83 (2006)
A major challenge facing liver transplant recipients and their physicians is recurrence of hepatitis C virus infection following otherwise technically successful liver transplantation. Recurrent infection leads to diminished graft and patient surviva
Externí odkaz:
https://doaj.org/article/17022328e3804225a0295fcf3979a27e